Terms: = Lung cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130
61 results:
1. Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/STAT3 signaling via transactivation of IL-6ST and IL-6 genes.
Jin X; Shang B; Wang J; Sun J; Li J; Liang B; Wang X; Su L; You W; Jiang S
Cell Death Dis; 2024 Feb; 15(2):148. PubMed ID: 38360812
[TBL] [Abstract] [Full Text] [Related]
2. CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection.
Ferrigno I; Verzellesi L; Ottone M; Bonacini M; Rossi A; Besutti G; Bonelli E; Colla R; Facciolongo N; Teopompi E; Massari M; Mancuso P; Ferrari AM; Pattacini P; Trojani V; Bertolini M; Botti A; Zerbini A; Giorgi Rossi P; Iori M; Salvarani C; Croci S
Inflamm Res; 2024 Apr; 73(4):515-530. PubMed ID: 38308760
[TBL] [Abstract] [Full Text] [Related]
3. Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway.
Liu B; Zheng X; Li J; Yao P; Guo P; Liu W; Zhao G
BMC Cancer; 2023 Nov; 23(1):1070. PubMed ID: 37932661
[TBL] [Abstract] [Full Text] [Related]
4. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
Wolf CL; Pruett C; Lighter D; Jorcyk CL
Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
[TBL] [Abstract] [Full Text] [Related]
5. Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell lung cancer: A Randomized Controlled Trial.
Verschraegen C; Andric Z; Moiseenko F; Makharadze T; Shevnya S; Oleksiienko A; Yañez Ruiz E; Kim S; Ahn K; Park T; Park S; Ju H; Ohe Y
BioDrugs; 2022 Nov; 36(6):749-760. PubMed ID: 36169807
[TBL] [Abstract] [Full Text] [Related]
6. Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema.
Ruwanpura SM; McLeod L; Dousha LF; Seow HJ; West AC; West AJ; Weng T; Alanazi M; MacDonald M; King PT; Bardin PG; Gabay C; Klinman DM; Bozinovski S; Vlahos R; Anderson GP; Rose-John S; Saad MI; Jenkins BJ
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2201494119. PubMed ID: 36037355
[TBL] [Abstract] [Full Text] [Related]
7. Incidence of lung and human papilloma virus-associated malignancies in HIV-infected patients.
Chaussade H; Le Marec F; Coureau G; Leleux O; Neau D; Lazaro E; Amadeo B; Duffau P; Ferrand H; Courtault C; Foucan AS; Wittkop L; Bonnet F
AIDS; 2022 Apr; 36(5):665-673. PubMed ID: 34923517
[TBL] [Abstract] [Full Text] [Related]
8. Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from lung cancer.
Gowda P; Patrick S; Joshi SD; Kumawat RK; Sen E
Inflammation; 2022 Feb; 45(1):172-179. PubMed ID: 34480250
[TBL] [Abstract] [Full Text] [Related]
9. PRMT5 Enables Robust STAT3 Activation via Arginine Symmetric Dimethylation of SMAD7.
Cai C; Gu S; Yu Y; Zhu Y; Zhang H; Yuan B; Shen L; Yang B; Feng XH
Adv Sci (Weinh); 2021 May; 8(10):2003047. PubMed ID: 34026434
[TBL] [Abstract] [Full Text] [Related]
10. FGFR leads to sustained activation of STAT3 to mediate resistance to EGFR-TKIs treatment.
Song X; Tang W; Peng H; Qi X; Li J
Invest New Drugs; 2021 Oct; 39(5):1201-1212. PubMed ID: 33829354
[TBL] [Abstract] [Full Text] [Related]
11. NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.
Lu G; Tian S; Sun Y; Dong J; Wang N; Zeng J; Nie Y; Wu K; Han Y; Feng B; Shang Y
Theranostics; 2021; 11(5):2460-2474. PubMed ID: 33500736
[No Abstract] [Full Text] [Related]
12. Interleukin 35 Delays Hindlimb Ischemia-Induced Angiogenesis Through Regulating ROS-Extracellular Matrix but Spares Later Regenerative Angiogenesis.
Fu H; Sun Y; Shao Y; Saredy J; Cueto R; Liu L; Drummer C; Johnson C; Xu K; Lu Y; Li X; Meng S; Xue ER; Tan J; Jhala NC; Yu D; Zhou Y; Bayless KJ; Yu J; Rogers TJ; Hu W; Snyder NW; Sun J; Qin X; Jiang X; Wang H; Yang X
Front Immunol; 2020; 11():595813. PubMed ID: 33154757
[TBL] [Abstract] [Full Text] [Related]
13. ["Point line anterograde dissection" for the safe preparation of supraclavicular flap].
Zhou J; Chen XH; Ma TY; Kuang YX; Zhou MJ; Cao LL; Wang XL; Cao L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Sep; 55(9):845-849. PubMed ID: 32911887
[No Abstract] [Full Text] [Related]
14. Chidamide increases the sensitivity of Non-small Cell lung cancer to Crizotinib by decreasing c-
Ding N; You A; Tian W; Gu L; Deng D
Int J Biol Sci; 2020; 16(14):2595-2611. PubMed ID: 32792859
[No Abstract] [Full Text] [Related]
15. Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.
Metcalfe RD; Putoczki TL; Griffin MDW
Front Immunol; 2020; 11():1424. PubMed ID: 32765502
[TBL] [Abstract] [Full Text] [Related]
16. Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.
Kim JW; Marquez CP; Sperberg RAP; Wu J; Bae WG; Huang PS; Sweet-Cordero EA; Cochran JR
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14110-14118. PubMed ID: 32522868
[TBL] [Abstract] [Full Text] [Related]
17. gp130 degradation induced by epirubicin contributes to chemotherapy efficacy.
Liu F; Jin H; Shen J; Wu D; Tian Y; Huang C
Biochem Biophys Res Commun; 2019 Nov; 519(3):572-578. PubMed ID: 31537377
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and lung cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 Receptor.
Aryappalli P; Shabbiri K; Masad RJ; Al-Marri RH; Haneefa SM; Mohamed YA; Arafat K; Attoub S; Cabral-Marques O; Ramadi KB; Fernandez-Cabezudo MJ; Al-Ramadi BK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491838
[TBL] [Abstract] [Full Text] [Related]
19. Association of Variants in IL6-Related Genes with lung cancer Risk in Moroccan Population.
Kaanane H; Senhaji N; Berradi H; Benchakroun N; Benider A; Karkouri M; El Attar H; Igot Casa ; Khyatti M; Nadifi S
Lung; 2019 Oct; 197(5):601-608. PubMed ID: 31468132
[TBL] [Abstract] [Full Text] [Related]
20. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the gp130/STAT3 signaling pathway.
Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q
Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929
[TBL] [Abstract] [Full Text] [Related]
[Next]
